Abstract
The spondylometaphyseal dysplasias (SMDs) are a group of about a dozen rare disorders characterized by short stature, irregular, flat vertebrae, and metaphyseal abnormalities. Aside from spondylometaphyseal dysplasia Kozlowski type (MIM 184252) caused by mutations in TRPV4 (MIM 605427) and spondyloenchondrodysplasia (MIM 607944) resulting from mutations in ACP5 (MIM 171640), the genetic etiologies of SMDs are unknown. 1 Two of these unexplained SMDs have ophthalmologic manifestations: SMD with cone-rod dystrophy (SMD-CRD [MIM 608940]) and axial SMD with retinal degeneration (MIM 602271). Delineated clinically a decade ago, SMD-CRD is a presumed autosomal-recessive disorder with postnatal growth deficiency leading to profound short stature; rhizomelia with bowing of the lower extremities; platyspondyly with anterior vertebral protrusions; progressive metaphyseal irregularity and cupping with shortened tubular bones; and early-onset, progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. 2‐5 In contrast to retinitis pigmentosa, the CRDs have early involvement of cone photoreceptors. 6
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.